Clinical research progress between MMP-9 and the invasion and metastasis of colorectal cancer

Abstract

HU Jun-Jie, XU Pei-Quan. Clinical research progress between MMP-9 and the invasion and metastasis of colorectal cancer[J]. Journal of International Oncology, 2014, 41(11): 833-836.

［1］ Tenesa A, Dunlop MG. New insights into the aetiology of colorectal cancer from genomewide association studies［J］. Nat Rev Genet， 2009， 10（6）:353358. ［2］ Zheng X, Wang L, Zhu Y, et al. The SNP rs961253 in 20p12.3 is associated with colorectal cancer risk: a casecontrol study and a metaanalysis of the published literature［J］. PLoS One， 2012， 7:e34625. ［3］ Gezen C, Kement M, Altuntas YE, et al. Results after multivisceral resections of locally advanced colorectal cancers: an analysis on clinical and pathological t4 tumors［J］. World J Surg Oncol， 2012， 10:39. ［4］ Vandooren J, PE VDS, Opdenakker G. Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase9 (MMP9): the next decade［J］. Crit Rev Biochem Mol Biol, 2013, 48(3):222272. ［5］ Groblewska M, Siewko M, Mroczko B， et al. The role of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) in the development of esophageal cancer［J］. Folia Histochem Cytobiol, 2012, (50):1219. ［6］ Garg P1, VijayKumar M， Wang L， et al. Matrix metalloproteinase9mediated tissue injury overrides the protective effect of matrix metalloproteinase2 during colitis［J］. Am J Physiol Gastrointest Liver Physiol, 2009, 296(2):G175184. ［7］ MotovaliBashi M, Sadeghi M, Hemmati S. Serum MMP9 level associated with initiation and progression steps of breast cancer in the Iranian population［J］. Reprod Sci, 2010, 17(6): 585589. ［8］ Lin F, Chengyao X, Qingchang L, et al. CRKL promotes lung cancer cell invasion through ERKMMP9 pathway［J］. Mol Carcinog, 2014， In press. ［9］ Wang Y, Qiu H, Hu W, et al. Overexpression of plateletderived growth factord promotes tumor growth and invasion in endometrial cancer［J］. Int J Mol Sci, 2014, 15(3):47804794. ［10］ Huang MY, Chen HC, Yang IP, et al. Tumorigenesis and tumor progression related gene expression profiles in colorectal cancer［J］. Cancer Biomark, 2013, 13(4):269279. ［11］ Dragutinovi′c VV, Radonji′c NV, Petronijevi′c ND. Matrix metalloproteinase2 (MMP2) and 9 (MMP9) in preoperative serum as independent prognostic markers in patients with colorectal cancer.［J］. Mol Cell Biochem, 2011, 355(12):173178. ［12］ Inafuku Y, Furuhata T, Tayama M, et al. Matrix metalloproteinase2 expression in stromal tissues is a consistent prognostic factor in stage Ⅱ colon cancer［J］. Cancer Sci， 2009， 100（5）:852858. ［13］ Bendardarf R, Buhmeida A, Hilska M, et al. MMP9 (gelatinase B) expression is associated with diseasefree survival and diseasespecific survival in colorectal cancer patients［J］. Cancer Invest， 2010， 28(1):3843. ［14］田小林, 朱小宝, 郭芳, 等. 结肠直肠癌Smad4,MMP9基因表达的相关研究［J］. 癌症进展, 2010, 8(2):183188. ［15］ Kessenbrock K, Plaks V, Werb Z. Matrix metalloproteinases: regulators of the tumor microenvironment［J］. Cell, 2010, 141(1):5267. ［16］ Roh SA, Choi EY, Cho DH, et al. Growth and invasion of sporadic colorectal adenocarcinomas in terms of genetic change［J］. J Korean Med Sci, 2010, 25(3):353360. ［17］邵惠杰, 张蕾, 符仲标, 等. 结肠腺癌组织中Bmi1 和MMP9 蛋白的表达及其意义［J］. 实用医学杂志, 2011, 27(21):10065725. ［18］侯福涛, 陈子华, 钱立元. BMI1和MMP9在结肠癌细胞中的表达及意义［J］. 中国普通外科杂志, 2010, 19(10):11031106. ［19］ Lee SJ, Kim WJ, Moon SK. Role of the p38 MAPK signaling pathway in mediating interleukin28Ainduced migration of UMUC3 cells［J］. Int J Mol Med, 2012, 30（4）:945952. ［20］ Yue WY， Chen ZP． Vasculogenic mimie~potential target for tumor therapy［J］． Ai Zheng， 2006， 25(7)：914916. ［21］ WelchReardon KM, Ehsan SM, Wang K, et al .Angiogenic sprouting is regulated by endothelial cell expression of Slug (Snai2)［J］. J Cell Sci， 2014, 38(6):625633. ［22］ Li CY， Yuan P， Lin SS， et al． Matrix metalloproteinase 9 expression and prognosis in colorectal cancer ：a metaanalysis［J］． Tumour Biol， 2013， 34（2）：735741．［23］黄炳臣, 罗春英, 陆海善, 等. 大肠腺癌中HSP27和MMP9的表达及意义［J］. 右江医学, 2010, 38(4):10031383. ［24］武欣，李坤，张凡，等. 大肠癌中CCR7、Lselectin、CD44v6和MMP9表达及其与淋巴转移的关系［J］. 临床与实验病理学杂志， 2013, 29(1):3235. ［25］ RedondoMuoz J，José Terol M，GarcíaMarco JA，et al．Matrix metalloproteinase9 is upregulated by CCL2/CCR7 interaction via extracelluar signalregulated kinase1／2 signaling and is involved in CCL21driven B cell chronic lymphocytic leukemia cell invasion and migration［J］． Blood， 2008， 111(1)：383386．［26］ Li J， Sun R， Tao K， et al． The CCL21／CCR7 pathway plays a key role in human colon cancer metastasis through regulation of matrix metalloproteinase9［J］． Dig Liver Dis， 2011， 43(1)：4047. ［27］ Kim HC, Kim YS, Oh HW, et al. Collagen triple helix repeat containing 1 (CTHRC1) acts via ERKdependent induction of MMP9 to promote invasion of colorectal cancer cells.［J］. Oncotarget, 2014, 5(2):51929. ［28］ Li Y, Li Y, Liu Y, et al. PAX6, a novel target of microRNA7, promotes cellular proliferation and invasion in human colorectal cancer cells［J］. Dig Dis Sci, 2014, 59(3):598606. ［29］ Hsu TI, Lin SC, Lu PS, et al. MMP7mediated cleavage of nucleolin at Asp255 induces MMP9 expression to promote tumor malignancy［J］. Oncogene, 2014, In press. ［30］ Brew K, Nagase H. The tissue inhibitors of metalloproteinases (TIMPs): an ancient family with structural and functional diversity［J］. Biochim Biophys Acta, 2010， 1803（1）:5571. ［31］ Tseng CN, Huang CF, Cho CL, et al. Brefeldin a effectively inhibits cancer stem celllike properties and MMP9 activity in human colorectal cancer Colo 205 cells［J］. Molecules, 2013, 18(9):1024210253. ［32］周太成, 杨劭宇, 罗宏图, 等. MMP9 介导结肠癌细胞sMICA蛋白脱落的研究［J］. 岭南现代临床外科, 2013, 13(4):315317.

[1]	Wang Ying, Liu Nan, Guo Bing.Advances of antibody-drug conjugate in the therapy of metastatic breast cancer[J]. Journal of International Oncology, 2024, 51(6): 364-369.
[2]	Zhang Rui, Chu Yanliu.Research progress of colorectal cancer risk assessment models based on FIT and gut microbiota[J]. Journal of International Oncology, 2024, 51(6): 370-375.
[3]	Gao Fan, Wang Ping, Du Chao, Chu Yanliu.Research progress on intestinal flora and non-surgical treatment of the colorectal cancer[J]. Journal of International Oncology, 2024, 51(6): 376-381.
[4]	Wang Junyi, Hong Kaibin, Ji Rongjia, Chen Dachao.Effect of cancer nodules on liver metastases after radical resection of colorectal cancer[J]. Journal of International Oncology, 2024, 51(5): 280-285.
[5]	Li Shuyue, Ma Chenying, Zhou Juying, Xu Xiaoting, Qin Songbing.Progress of radiotherapy in oligometastatic non-small cell lung cancer[J]. Journal of International Oncology, 2024, 51(3): 170-174.
[6]	Sun Guobao, Yang Qian, Zhuang Qingchun, Gao Binbin, Sun Xiaogang, Song Wei, Sha Dan.Research progress on the histopathological growth patterns of colorectal liver metastasis[J]. Journal of International Oncology, 2024, 51(2): 114-118.
[7]	Liu Debao, Sun Ziwen, Lu Shoutang, Xu Haidong.Expression and clinical significance of ASB6 in colorectal cancer tissues[J]. Journal of International Oncology, 2023, 50(8): 470-474.
[8]	Zhang Lu, Jiang Hua, Lin Zhou, Ma Chenying, Xu Xiaoting, Wang Lili, Zhou Juying.Analysis of curative effect and prognosis of immune checkpoint inhibitor in the treatment of recurrent and metastatic cervical cancer[J]. Journal of International Oncology, 2023, 50(8): 475-483.
[9]	Chen Zhuo, Tao Jun, Chen Lin, Ke Jing.Value of detection of peripheral blood miR-194 combined with fecal miR-143 in the clinical screening of colorectal cancer[J]. Journal of International Oncology, 2023, 50(5): 268-273.
[10]	Yang Lirong, Wang Yufeng.Construction of machine learning models for predicting the risk of postoperative distant metastasis recurrence in serous ovarian cancer[J]. Journal of International Oncology, 2023, 50(4): 220-226.
[11]	Huang Zhen, Zhang Caiyutian, Ke Shaobo, Shi Wei, Zhao Wensi, Chen Yongshun.Construction of postoperative prognosis model for patients with colorectal cancer[J]. Journal of International Oncology, 2023, 50(3): 157-163.
[12]	Xu Liangfu, Li Yuanfei.Research progress on tumor microenvironment and immune combination therapy of MSS colorectal cancer[J]. Journal of International Oncology, 2023, 50(3): 186-190.
[13]	Ma Peihan, Zhang Lingming, Lu Ning, Zhang Mingxin.Effect of anesthesia on the recurrence and metastasis of hepatocellular carcinoma[J]. Journal of International Oncology, 2023, 50(2): 117-121.
[14]	Liu Yujie, Zhao Zhiqiang, Wang Zicheng.Levels and diagnostic value of TOP2A and ERBB2 in peripheral blood mononuclear cells of patients with early colorectal cancer[J]. Journal of International Oncology, 2023, 50(12): 717-722.
[15]	Tao Hong, Yin Hong, Luo Hong, Tao Jiayu.Potential strategies for targeting tumor-associated macrophages to enhance the efficacy of immune checkpoint inhibitors for colorectal cancer[J]. Journal of International Oncology, 2023, 50(11): 683-687.

Clinical research progress between MMP-9 and the invasion and metastasis of colorectal cancer

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles15

Recommended Articles

Metrics

Comments